1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Insomnia Disorders: new trials by email Literature Review of Insomnia Disorders trials Research Report on Insomnia Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder Placebo, JNJ-42847922, 5 mg, JNJ-42847922, 10 mg - Insomnia Disorders | Phase 2 | Completed | Janssen Research & Development, LLC | 365 | 2017-11-23 | 2025-04-29 |
Sleep Initiation and Maintenance Disorders (1)
Dyssomnias (1) · Mental Disorders (1) · Nervous System Diseases (1) · Sleep Disorders, Intrinsic (1) · Sleep Wake Disorders (1)
Zolpidem (1) · seltorexant (1)
Janssen Research & Development, LLC (1)
Belgium (1) · France (1) · Germany (1) · Japan (1) · Poland (1) · United States (1)
2017 (1)